Mutational analysis of the Epstein—Barr virus nuclear antigen 2 by far-Western blotting and DNA-binding studies

References

1. Billaud M., Busson P., Huang D., Mueller-Lantzsch N., Rousselet G., Pavlish O., Wakasugi H., Seigneurin J. M., Tursz T., Lenoir G. M. 1989; Epstein–Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2. Journal of Virology 63:4121–4128
   [Google Scholar]
2. Cohen J. I., Wang F., Kieff E. 1991; Epstein–Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. Journal of Virology 65:2545–2554
   [Google Scholar]
3. Grässer F. A., Haiss P., Göttel S., Mueller-Lantzsch N. 1991; Biochemical characterization of Epstein–Barr virus nuclear antigen 2A. Journal of Virology 65:3779–3788
   [Google Scholar]
4. Grässer F. A., Sauder C., Haiss P., Hille A., König S., Göttel S., Kremmer E., Leinenbach H. P., Zeppezauer M., Mueller-Lantzsch N. 1993; Immunological detection of proteins associated with the Epstein–Barr virus nuclear antigen 2A. Virology 195:550–560
   [Google Scholar]
5. Hammerschmidt W., Sugden B. 1989; Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes. Nature 340:393–397
   [Google Scholar]
6. Henkel T., Ling P. D., Hayward S. D., Peterson M. G. 1994; Mediation of Epstein–Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265:92–95
   [Google Scholar]
7. Hsieh J. J. D., Hayward S. D. 1995; Masking the CBF1/RBPJ _к , transcriptional repression domain by Epstein–Barr virus EBNA2. Science 268:560–563
   [Google Scholar]
8. King L. A., Possee R. D. 1992; The Baculovirus Expression System –A Laboratory Guide. London: Chapman & Hall;
   [Google Scholar]
9. Kremmer E., Kranz B., Hille A., Klein K., Eulitz M., Hoffmann-Fezer G., Feiden W., Herrmann K., Delecluse H.-J., Delsol G., Bornkamm G. W., Mueller-Lantzsch N., Grässer F. A. 1995; Rat monoclonal antibodies differentiating between the Epstein–Barr virus nuclear antigen 2A (EBNA2A) and 2B (EBNA2B). Virology 208:336–342
   [Google Scholar]
10. Laux G., Adam B., Strobl L. J., Moreau-Gachelin F. 1994; The Spi-l/PU.l and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein–Barr virus nuclear antigen 2 responsive cis-element. EMBO Journal 13:5624–5632
    [Google Scholar]
11. Ling P. D., Hayward S. D. 1995; Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBFI/RBPJ _к . Journal of Virology 69:1944–1950
    [Google Scholar]
12. Ling P. D., Hsieh J. J., Ruf I. K., Rawlins D. R., Hayward S. D. 1994; EBNA-2 upregulation of Epstein–Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. Journal of Virology 68:5375–5383
    [Google Scholar]
13. Middleton T., Gahn T. A., Martin J. M., Sugden B. 1991; Immortalizing genes of Epstein–Barr virus. Advances in Virus Research 40:19–55
    [Google Scholar]
14. Miller G. 1990; Epstein–Barr virus: biology, pathogenesis and medical aspects. In Virology 2nd edn pp 1921–1958 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
15. Ring J. A. 1994; The B cell-immortalizing functions of Epstein–Barr virus. Journal of General Virology 75:1–13
    [Google Scholar]
16. Sauder C., Haiss P., Grässer F. A., Zimber-Strobl U., Mueller-Lantzsch N. 1994; DNA-binding studies of the Epstein–Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines. Journal of General Virology 75:3067–3079
    [Google Scholar]
17. Tong X., Yalamanchili R., Harada S., Kieff E. 1994; The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains. Journal of Virology 68:6188–6197
    [Google Scholar]
18. Tong X., Drapkin R., Yalamanchili R., Mosialos G., Kieff E. 1995; The Epstein–Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Molecular and Cellular Biology 15:4735–4744
    [Google Scholar]
19. Tsui S., Schubach W. H. 1994; Epstein–Barr virus nuclear protein 2A forms oligomers in vitro and in vivo through a region required for B-cell transformation. Journal of Virology 68:4287–4294
    [Google Scholar]
20. Zimber-Strobl U., Strobl L. J., Meitinger C., Hinrichs R., Sakai T., Furukawa T., Honjo T., Bornkamm G. 1994; Epstein–Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBPJ _к , the homologue of Drosophila suppressor of hairless. EMBO Journal 13:4973–4982
    [Google Scholar]